CLARUS THERAPEUTICS HLDNGS I
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for CLARUS THERAPEUTICS HLDNGS I *W EXP 08/11/202, CUSIP 18271L115.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for CLARUS THERAPEUTICS HLDNGS I *W EXP 08/11/202, CUSIP 18271L115.